000 01487 a2200397 4500
005 20250515234838.0
264 0 _c20110131
008 201101s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00462-10
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaubon, Danièle
245 0 0 _aActivity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cNov 2010
300 _a4843-50 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntiprotozoal Agents
_xpharmacology
650 0 4 _aBlotting, Western
650 0 4 _aFemale
650 0 4 _aHistone Deacetylase Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMicroscopy, Fluorescence
650 0 4 _aPeptides, Cyclic
_xdrug effects
650 0 4 _aToxoplasma
_xcytology
650 0 4 _aToxoplasmosis
_xdrug therapy
700 1 _aBougdour, Alexandre
700 1 _aWong, Yung-Sing
700 1 _aBrenier-Pinchart, Marie-Pierre
700 1 _aCurt, Aurélie
700 1 _aHakimi, Mohamed-Ali
700 1 _aPelloux, Hervé
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 54
_gno. 11
_gp. 4843-50
856 4 0 _uhttps://doi.org/10.1128/AAC.00462-10
_zAvailable from publisher's website
999 _c20049938
_d20049938